Navigation Links
Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report
Date:1/19/2012

nology ("HIT") mergers and acquisitions market was robust in 2011 as buyers looked to acquire rapidly growing companies, principally software enabled solutions (SaaS and Cloud enabled), in highly attractive niches to accelerate their own growth and offer fuller suites of world class products to the dynamic and growing healthcare marketplace," said Tom O'Connor, Managing Director in Berkery Noyes' Healthcare and Life Sciences group. "In 2012, we expect to see an increased deal flow and attractive prices for sellers from both strategic and financial buyers, but strategic buyers, like in 2011, will dominate the buyer universe."

According to Jonathan Krieger, Managing Director in Berkery Noyes' Healthcare and Life Sciences group, "The number of HIT transactions increased for the 3rd consecutive year and valuation multiples continued to rise. The enactment of the HITECH Act has catalyzed the adoption of IT by both payors and providers and has resulted in a very favorable M&A market for private companies that wish to pursue liquidity events."

Berkery Noyes specializes in structuring debt and equity transactions in the $25 million to $500 million range, a market that is enjoying a surge in activity. Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and current information. The firm's research teams publish acquisition activity in the respective sectors they follow on MandAsoft.com.

A copy of the FULL YEAR 2011 PHARMA & HEALTHCARE INFORMATION AND TECHNOLOGY INDUSTRY M&A TREND REPORT is available at the Berkery Noyes website.

About Berkery Noyes <
'/>"/>

SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
2. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
3. Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
4. Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. CEL-SCI Corporation Releases Letter to Shareholders
7. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
8. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
9. Immunosyn Corporation Releases SF-1019 Study Results
10. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
11. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the patented biopharmaceutical, modernized traditional Chinese ... (API) released unaudited preliminary financial results for the ... Fiscal Year 2015 Ended September 30, 2014 Financial ... with $14.7 million in 1Q14 with gross margins ...
(Date:12/24/2014)... , Dec. 24, 2014  The International Trade Commission (ITC) ... (RMD) against BMC Medical. In a notice issued on December ... that ResMed,s patent on its humidifier was invalid. ... "monumental win". "We are very excited with the ITC,s decision ... that we have taken since the very beginning on the ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
... SAN DIEGO, March 20, 2012  HUYA Bioscience International ... of China,s preeminent pharmacological researchers, Prof. Deyong Ye ... an international leader in supporting the global development ... Fudan University will focus on specific innovations coming ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Ibandronate Sodium Tablets, 150mg. This product is the generic ... treatment and prevention of osteoporosis in postmenopausal women. ...
Cached Medicine Technology:HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 2HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 3
(Date:12/24/2014)... 24, 2014 Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... tort litigation currently underway in Pennsylvania’s Philadelphia Court of ... December 24, 2014, court documents indicate that 1,183 claims ... individuals who developed gynecomastia (male breast growth) and other ... Court indicates that this represents an increase of more ...
(Date:12/24/2014)... Dallas, TX (PRWEB) December 24, 2014 ... has announced the expansion of his practice and med-spa ... to the practice’s growing list of cosmetic treatments and ... a solution into the skin,” says Dr. Ho. “As ... aging changes such as wrinkles, sun spots, discolorations or ...
(Date:12/24/2014)... the famous women’s dress supplier, has presented its new selection ... gown promotion. , For those who prefer to ... the collection should be a great choice. The dresses from ... are available with custom service. , Now, all the wedding ... 75% off; most of them come in hot designs. In ...
(Date:12/24/2014)... The report “Stivarga (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... which is used in the treatment of colon or ... also prescribed to patients who suffer from advanced gastrointestinal ... a multi-kinase inhibitor and it blocks many enzymes which ...
(Date:12/24/2014)... 2014 BambooIndustry.com a famous bamboo flooring ... Today, the company announces its multiple layer bamboo ... on these new products. , Bamboo panel is the ... multiple layer bamboo panel board features high quality selective ... emissions free. The bamboo panel consists of multiple layers ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2
... Homegrown pharma major Panacea Biotec today said it is ... and Japanese encephalitis. // ,"We are currently ... and hepatitis-A. Phase I and II trials for anthrax ... approvals," Panacea Biotec Joint Managing Director Rajesh Jain told ...
... or lesions, that typically precede cervical cancer is much ... human papillomavirus (HPV) than previously reported, according to a ... Biomarkers & Prevention. ,Although doctors have known ... womb can harbor multiple HPV types, this study is ...
... Researchers in the Newcastle University at New South Wales central ... chlamydia and they have received financial// support from the vaccine ... they have developed techniques to immunise animals against the infection. ... researchers are working very hard for the past seven years ...
... U.S. Food and Drug Administration (FDA), along with Publix ... warning against allergen in Publix brand// Chocolate Chip Cookie ... director of media and community relations, "The chocolate ... precaution, we are recalling the product. There have been ...
... A 20-year study of women in the Nurses' Health Study ... open angle glaucoma (POAG), the most common form of glaucoma//, ... study is published in the July issue of the journal ... Infirmary, Brigham and Women's ,Hospital, Harvard School of Public Health ...
... that Statin drugs used to reduce the levels of ... of HDL can cause serious muscle// damage. ... such as Lipitor, Pravachol, Zocor, Crestor and Mevacor to ... damage on patient safety information sheets. ,Statin ...
Cached Medicine News:Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 2Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 3Health News:Type 2 Diabetes Increases the Risk of Glaucoma in Women 2
... laboratories that have decided to change to the ... the RELISA ANAs correlation with IFA and many ... competition. While no ELISA ANA currently on the ... our RELISA ANA screen has been shown to ...
... HEp-2 cell line that has been genetically ... autoantibodies, without affecting the other ANA patterns ... worldwide on the HEp-2000 ANA substrate, which ... used in place of standard HEp-2 cells ...
... ENA assays can be used to ... antibodies, which are associated with various ... lupus erythematosus (Lupus), Sjgren's syndrome, mixed ... scleroderma, polymyositis, dermatomyositis, and Raynaud's phenomenon. ...
... Indirect Fluorescence Assay (IFA) for Anti-native ... for the qualitative and semi-quantitative detection ... nDNA in human serum. Detection of ... be used as an aid in ...
Medicine Products: